ASHLEY TENNILL: Open Payments
NPI 1629405907 · MATTOON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,642 in 122 payments from 27 companies in 2025. Trend: 2023 $118 · 2024 $1,915 · 2025 $2,642
Food & beverage: $2,281Education: $361
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 29 | $448 |
| AstraZeneca Pharmaceuticals LP | 13 | $342 |
| Janssen Biotech, Inc. | 13 | $315 |
| Incyte Corporation | 7 | $249 |
| Daiichi Sankyo Inc. | 11 | $186 |
| Merck Sharp & Dohme LLC | 8 | $177 |
| Regeneron Healthcare Solutions, Inc. | 4 | $104 |
| SEAGEN INC. | 1 | $100 |
| EMD Serono, Inc. | 3 | $62 |
| GlaxoSmithKline, LLC. | 3 | $62 |
Products named: Enhertu, IMFINZI, KEYTRUDA, KISQALI, RYBREVANT, Fabhalta, LIBTAYO, LYNPARZA.
Industry payments across IL — which companies pay providers there.
